Literature DB >> 12926584

Probabilistic sensitivity analysis for decision trees with multiple branches: use of the Dirichlet distribution in a Bayesian framework.

Andrew H Briggs1, A E Ades, Martin J Price.   

Abstract

In structuring decision models of medical interventions, it is commonly recommended that only 2 branches be used for each chance node to avoid logical inconsistencies that can arise during sensitivity analyses if the branching probabilities do not sum to 1. However, information may be naturally available in an unconditional form, and structuring a tree in conditional form may complicate rather than simplify the sensitivity analysis of the unconditional probabilities. Current guidance emphasizes using probabilistic sensitivity analysis, and a method is required to provide probabilistic probabilities over multiple branches that appropriately represents uncertainty while satisfying the requirement that mutually exclusive event probabilities should sum to 1. The authors argue that the Dirichlet distribution, the multivariate equivalent of the beta distribution, is appropriate for this purpose and illustrate its use for generating a fully probabilistic transition matrix for a Markov model. Furthermore, they demonstrate that by adopting a Bayesian approach, the problem of observing zero counts for transitions of interest can be overcome.

Mesh:

Year:  2003        PMID: 12926584     DOI: 10.1177/0272989X03255922

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  53 in total

1.  Value-of-information analysis to reduce decision uncertainty associated with the choice of thromboprophylaxis after total hip replacement in the Irish healthcare setting.

Authors:  Laura McCullagh; Cathal Walsh; Michael Barry
Journal:  Pharmacoeconomics       Date:  2012-10-01       Impact factor: 4.981

2.  Modelling human resources policies with Markov models: an illustration with the South African nursing labour market.

Authors:  Mylene Lagarde; John Cairns
Journal:  Health Care Manag Sci       Date:  2011-11-15

3.  Calibration of complex models through Bayesian evidence synthesis: a demonstration and tutorial.

Authors:  Christopher H Jackson; Mark Jit; Linda D Sharples; Daniela De Angelis
Journal:  Med Decis Making       Date:  2013-07-25       Impact factor: 2.583

4.  Assessing the real-world cost-effectiveness of adjuvant trastuzumab in HER-2/neu positive breast cancer.

Authors:  Lindsay Hedden; Susan O'Reilly; Caroline Lohrisch; Stephen Chia; Caroline Speers; Laurel Kovacic; Suzanne Taylor; Stuart Peacock
Journal:  Oncologist       Date:  2012-02-02

5.  Cost-effectiveness of referrals to high-volume hospitals: an analysis based on a probabilistic Markov model for hip fracture surgeries.

Authors:  Afschin Gandjour; Eva-Julia Weyler
Journal:  Health Care Manag Sci       Date:  2006-11

6.  Cost-Effectiveness of a Biopsy-Based 8-Protein Prostate Cancer Prognostic Assay to Optimize Treatment Decision Making in Gleason 3 + 3 and 3 + 4 Early Stage Prostate Cancer.

Authors:  Joshua A Roth; Scott D Ramsey; Josh J Carlson
Journal:  Oncologist       Date:  2015-10-19

7.  Statin therapy in rheumatoid arthritis: a cost-effectiveness and value-of-information analysis.

Authors:  Nick Bansback; Roberta Ara; Sue Ward; Aslam Anis; Hyon K Choi
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

8.  Cost-effectiveness of apixaban vs. other new oral anticoagulants for the prevention of stroke: an analysis on patients with non-valvular atrial fibrillation in the Greek healthcare setting.

Authors:  Kostas Athanasakis; Eleftheria Karampli; Dimitrios Tsounis; Aikaterini Bilitou; John Kyriopoulos
Journal:  Clin Drug Investig       Date:  2015-11       Impact factor: 2.859

9.  Joint assessment of intended and unintended effects of medications: an example using vascular endothelial growth factor inhibitors for neovascular age-related macular degeneration.

Authors:  Adrian R Levy; Shelagh Szabo; Andrew Briggs; Andreas Pleil; Alison Davie; Gergana Zlateva; Jonathan Javitt
Journal:  J Ophthalmol       Date:  2010-02-16       Impact factor: 1.909

10.  Do the potential benefits of metal-on-metal hip resurfacing justify the increased cost and risk of complications?

Authors:  Kevin J Bozic; Christine M Pui; Matthew J Ludeman; Thomas P Vail; Marc D Silverstein
Journal:  Clin Orthop Relat Res       Date:  2010-09       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.